Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 175

The DOI matches its Crossref record.

Nonpeptide AVE 0991 Is an Angiotensin-(1–7) Receptor Mas Agonist in the Mouse Kidney

Open access
Pinheiro, Sérgio Veloso Brant, Simões e Silva, Ana Cristina, Sampaio, Walkyria Oliveira, de Paula, Renata Dutra, Mendes, Elizabeth Pereira, Bontempo, Elizabete Dias, Pesquero, João Bosco, Walther, Thomas, Alenina, Natalia, Bader, Michael, Bleich, Markus, Santos, Robson Augusto Souza·2004·Hypertension

Abstract

It has been described recently that the nonpeptide AVE 0991 (AVE) mimics the effects of angiotensin-(1–7) [Ang-(1–7)] in bovine endothelial cells. In this study, we tested the possibility that AVE is an agonist of the Ang-(1–7) receptor Mas, in vitro and in vivo. In water-loaded C57BL/6 mice, AVE (0.58 nmol/g body weight) produced a significant reduction in urinary volume (0.06±0.03 mL/60 min [n=9] versus 0.27±0.05 [n=9]; P <0.01), associated with an increase in urinary osmolality. The Ang-(1–7) antagonist A-779 completely blocked the antidiuretic effect of AVE. As observed previously for Ang-(1–7), the antidiuretic effect of AVE after water load was blunted in Mas -knockout mice (0.37±0.10 mL/60 min [n=9] versus 0.27±0.03 mL/60 min [n=11] AVE-treated mice). In vitro receptor autoradiography in C57BL/6 mice showed that the specific binding of 125 I-Ang-(1–7) to mouse kidney slices was displaced by AVE, whereas no effects were observed in the binding of 125 I-angiotensin II or 125 I-angiotensin IV. Furthermore, AVE displaced the binding of 125 I-Ang-(1–7) in Mas -transfected monkey kidney cells (COS) cells (IC 50 =4.75×10 −8 mol/L) and of rhodamine–Ang-(1–7) in Mas -transfected Chinese hamster ovary (CHO) cells. It also produced NO release in Mas -transfected CHO cells blocked by A-779 but not by angiotensin II type-1 (AT 1 ) and AT 2 antagonists. Contrasting with these data, the antidiuretic effect of AVE was totally blocked by AT 2 antagonists and partially blocked (≈60%) by AT 1 antagonists. The binding data, the results obtained in Mas -knockout mice and in Mas -transfected cells, show that AVE is a Mas receptor agonist. Our data also suggest the involvement of AT 2 /AT 1 -related mechanisms, including functional antagonism, oligomerization or cross-talk, in the renal responses to AVE.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.hyp.0000141438.64887.42

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 175

Metadata

Authors
Pinheiro, S. V. B., Simões e Silva, A. C., Sampaio, W. O., de Paula, R. D., Mendes, E. P., Bontempo, E. D., Pesquero, J. B., Walther, T., Alenina, N., Bader, M., Bleich, M., & Santos, R. A. S.
Venue
Hypertension
Published
2004-10
Volume
44
Issue
4
Pages
490-496
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
OpenAlex
W2137225581
Cited by
175
References
0
FWCI
6.20
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nonpeptide AVE 0991 Is an Angiotensin-(1–7) Receptor Mas Agonist in the Mouse Kidney. https://app.cochat.ai/papers/10.1161/01.hyp.0000141438.64887.42
The paper
Pinheiro, S. V. B., Simões e Silva, A. C., Sampaio, W. O., de Paula, R. D., Mendes, E. P., Bontempo, E. D., Pesquero, J. B., Walther, T., Alenina, N., Bader, M., Bleich, M., & Santos, R. A. S. (2004). Nonpeptide AVE 0991 Is an Angiotensin-(1–7) Receptor Mas Agonist in the Mouse Kidney. Hypertension. https://doi.org/10.1161/01.hyp.0000141438.64887.42

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.